These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 6418110)

  • 1. Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression.
    Heninger GR; Charney DS; Sternberg DE
    Arch Gen Psychiatry; 1983 Dec; 40(12):1335-42. PubMed ID: 6418110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.
    de Montigny C; Cournoyer G; Morissette R; Langlois R; Caillé G
    Arch Gen Psychiatry; 1983 Dec; 40(12):1327-34. PubMed ID: 6418109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression.
    Kramlinger KG; Post RM
    Arch Gen Psychiatry; 1989 Sep; 46(9):794-800. PubMed ID: 2505730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of response to lithium augmentation in refractory depression.
    Price LH; Charney DS; Heninger GR
    Am J Psychiatry; 1986 Nov; 143(11):1387-92. PubMed ID: 3096155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefit of lithium carbonate adjunct in refractory depression--fact or fiction?
    Kantor D; McNevin S; Leichner P; Harper D; Krenn M
    Can J Psychiatry; 1986 Jun; 31(5):416-8. PubMed ID: 3089576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.
    Joffe RT; Singer W; Levitt AJ; MacDonald C
    Arch Gen Psychiatry; 1993 May; 50(5):387-93. PubMed ID: 8489327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.
    Bauer M; Bschor T; Kunz D; Berghöfer A; Ströhle A; Müller-Oerlinghausen B
    Am J Psychiatry; 2000 Sep; 157(9):1429-35. PubMed ID: 10964859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies.
    Bauer M; Dopfmer S
    J Clin Psychopharmacol; 1999 Oct; 19(5):427-34. PubMed ID: 10505584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium carbonate augmentation of desipramine in refractory depression.
    Dallal A; Fontaine R; Ontiveros A; Elie R
    Can J Psychiatry; 1990 Oct; 35(7):608-11. PubMed ID: 2125237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression.
    Januel D; Poirier MF; D'alche-Biree F; Dib M; Olié JP
    J Affect Disord; 2003 Sep; 76(1-3):191-200. PubMed ID: 12943949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action.
    Charney DS; Price LH; Heninger GR
    Arch Gen Psychiatry; 1986 Dec; 43(12):1155-61. PubMed ID: 3022664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of lithium-tranylcypromine treatment in refractory depression.
    Price LH; Charney DS; Heninger GR
    Am J Psychiatry; 1985 May; 142(5):619-23. PubMed ID: 3920923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding lithium to antidepressant therapy: factors related to therapeutic potentiation.
    Rybakowski J; Matkowski K
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):161-5. PubMed ID: 1633434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium as an adjunct in the treatment of major depression.
    Browne M; Lapierre YD; Hrdina PD; Horn E
    Int Clin Psychopharmacol; 1990 Apr; 5(2):103-10. PubMed ID: 2116474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of lithium to augment antidepressant medication.
    Rouillon F; Gorwood P
    J Clin Psychiatry; 1998; 59 Suppl 5():32-9; discussion 40-1. PubMed ID: 9635546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory depression: the addition of lithium to fluoxetine or desipramine.
    Ontiveros A; Fontaine R; Elie R
    Acta Psychiatr Scand; 1991 Mar; 83(3):188-92. PubMed ID: 1903237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major depression in renal dialysis patients: an open trial of antidepressant therapy.
    Kennedy SH; Craven JL; Rodin GM
    J Clin Psychiatry; 1989 Feb; 50(2):60-3. PubMed ID: 2644243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rapid response of a disorder to the addition of lithium carbonate: panic resistant to tricyclic antidepressants].
    Cournoyer J
    Can J Psychiatry; 1986 May; 31(4):335-8. PubMed ID: 3085912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium augmentation in psychotic depression refractory to combined drug treatment.
    Nelson JC; Mazure CM
    Am J Psychiatry; 1986 Mar; 143(3):363-6. PubMed ID: 2869701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.